Published in Health Insurance Week, May 1st, 2005
O. Watanabe and colleagues, Tokyo Women's Medical University, wrote, "Twist, a transcription factor of the basic helix-loophelix class, has been suggested to have oncogenic properties. We reported Twist expression was regulated by Wnt/beta-catenin signaling and that both Wnt-1 and Twist could contribute to mammary tumorigenesis.
"The aim of this study was to demonstrate the expression of Twist, Will-1, and Wnt-2 in human breast cancer tissue."
The researchers "examined the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.